News
Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Thursday before the bell. Here’s what ...
Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
7h
Investor's Business Daily on MSNInspire Medical Systems Crashes 32% As Eli Lilly's GLP-1 Weighs On GuidanceInspire Medical Systems crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 drugs for ...
Eli Lilly and Co.'s Kenosha County project will be eligible for the largest tax break ever under the state of Wisconsin's ...
At least 26 patients have filed lawsuits in Marion County against Eli Lilly and Co. over its marketing of GLP-1 drugs ...
The amount of credits the company receives is contingent upon its meeting job creation and capital investment goals.
Hyderabad: Pharma giant Eli Lilly and Company (India) opened its new technology and innovation centre in Hyderabad's Hitech ...
Hyderabad: Ina major boost to Telangana’s life sciences and innovation ecosystem, global pharmaceutical giant Eli Lilly ...
Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...
The Wisconsin Economic Development Corp. is offering pharmaceutical giant Eli Lilly up to $100 million in tax credits to ...
Telangana Chief Minister A. Revanth Reddy inaugurated US pharma major Eli Lilly’s Global Capability Centre (GCC) in Hyderabad ...
Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results